Home/ Supplements/ Astragalus/ Astragalus Root 200 mg

Astragalus Root 200 mg

product on market Capsule Thompson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Astragalus root is researched for its potential to support immune function and reduce inflammation. Current clinical evidence for these effects is limited due to a lack of large-scale human trials. This ingredient is generally considered safe for most users.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Astragalus Root 200 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

200 mg
Market median: 470.0mg (230 products) 9 studies (A:3, B:3)

Other Ingredients

Gelatin Cellulose Astragalas Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: Use only as directed. Take one capsule daily with a meal or glass of water.

Warnings & Precautions

WARNING: Do not use if safety seal is broken or missing.

Keep out of reach of children

Additional Information

SINCE 1932

STANDARDIZED EXTRACT

FRESH HEALTHY

Keep your licensed health care practitioner informed when using this product.

Store in a cool, dry place.

Discussion: Astragalus is valued for its tonic and adaptogenic effects. It is one of the most popular herbs in China.

1381429 1007

ONCE DAILY

Metadata

Product Details

UPC / SKU0 31315 19221 0
DSLD Entry Date2014-08-26
Product TypeBotanical
FormCapsule
DSLD ID36418
Data Updated2026-04-11
Research

Research Evidence

9
Research Sources
60
Avg Quality
5
Meta Analysis
2
Cochrane Review
1
Systematic Review
1
Rct
B Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Evaluating traditional Chinese medicine (TCM) Jie Geng and Huang Qi combination on reducing surgical site infections in colorectal cancer surgeries: A systematic review and meta-analysis
Meta Analysis International wound journal 2024 PubMed DOI
B Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract
Rct BMJ supportive & palliative care 2025 PubMed DOI
B Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation
Meta Analysis Renal failure 2025 PubMed DOI
B Renal protective effects and mechanisms of Astragalus membranaceus for diabetic kidney disease in animal models: An updated systematic review and meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 PubMed DOI
C Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review
Systematic Review Metabolic brain disease 2020 PubMed DOI
C Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
Meta Analysis Integrative cancer therapies 2025 PubMed DOI
C The Effect of Astragalus on Humoral and Cellular Immune Response: A Systematic Review and Meta-Analysis of Human Studies
Meta Analysis Complementary medicine research 2023 PubMed DOI
View all evidence for Astragalus →
Compare

Similar Products

View all Astragalus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.